|
AXSM Axsome Therapeutics Inc 1579428 |
| Balance Sheet |
|
Current Assets
|
479,113,000 |
|
Assets
|
561,458,000 |
|
Current Liabilities
|
196,187,000 |
|
Liabilities
|
468,560,000 |
|
Equity
|
92,898,000 |
|
Shares Out
|
48,000,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-102,208,000 |
|
Investing Cash Flow
|
-240,000 |
| Market Analysis |
Market Cap
|
4,377,378,224 |
|
Price
|
91.94 |
|
BVPS
|
1.94 |
|
PB
|
47.50 |
|
EPS
|
-6.51 |
|
PS
|
10.45 |
|
FCF
|
-102,448,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AXSM documents filed with the SEC.
AXSM Filings
Clear
